Trial intelligence / Profile preview

Hypertonic saline – effect of repeated doses on intraocular pressure

2013-001733-41Phase 4Completed

Sponsor
Harju Mika
Start
Jun 2013
Countries
1
01

Overview

Phase 4 trial of sodium chloride in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Harju Mika. Primary endpoint: Change in intraocular pressure after hypertonic saline dosing. Started Jun 2013; status: completed.

02

Drugs

sodium chloride
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on 2013-001733-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001733-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call